Skip to main content

Animations

MJFF Publications

3441 - 3450 of 8404 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • Summary Details
    OPEN
    Title: Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
    Journal Name: Biomedicines
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biomedicines9050514
    Citation Count: 6
  • Summary Details
    OPEN
    Title: Scoring Algorithm‐Based Genomic Testing in Dystonia: A Prospective Validation Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28614
    Citation Count: 17
  • Summary Details
    OPEN
    Title: Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
    Journal Name: EMBO Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.15252/emmm.202114022
    Citation Count: 153
  • Summary Details
    RESTRICTED
    Title: Effect of gender in the onset and progression of Parkinson's disease
    Journal Name: 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1109/ner49283.2021.9441293
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Expectations of Benefit in a Trial of a Candidate Disease‐Modifying Treatment for Parkinson Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28630
    Best OA location URL:
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Exploring new uses for existing drugs: innovative mechanisms to fund independent clinical research
    Journal Name: Trials
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s13063-021-05273-x
    Citation Count: 31
  • Summary Details
    RESTRICTED
    Title: Investigating Cognitive Global Coordination in normal and autistic children using virtual reality environments – An EEG Study
    Journal Name: 2021 10th International IEEE/EMBS Conference on Neural Engineering (NER)
    Publisher: IEEE
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1109/ner49283.2021.9441259
    Best OA location URL:
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.28608
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26094
    Citation Count: 41
  • Summary Details
    RESTRICTED
    Title: Ischemic Events After Intracerebral Hemorrhage
    Journal Name: JAMA Neurology
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.0772
    Best OA location URL:
    Citation Count: 3
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.